---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-120015"
form_type: "8-K"
ticker: "GPCR"
cik: "0001888886"
company_name: "Structure Therapeutics Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:40:57.903825+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Structure Therapeutics launches $650M follow-on offering of ADSs and pre-funded warrants

## Summary
- Gross proceeds ~$650M from 8.46M ADSs at $65.00 and 1.54M pre-funded warrants at $64.9999.
- Underwriters include Jefferies, Leerink, Goldman Sachs, Morgan Stanley; 30-day option for 1.5M additional ADSs.
- Closing expected Dec 11, 2025; pre-funded warrants have 9.99% beneficial ownership limit (can increase to 19.99%).
- Offering made under effective shelf registration; proceeds before underwriting discounts and expenses.

## SEC filing metadata
- accession: 0001104659-25-120015
- form_type: 8-K
- ticker: GPCR
- cik: 0001888886
- company_name: Structure Therapeutics Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1888886/000110465925120015/0001104659-25-120015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1888886/000110465925120015/tm2532078d5_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-120015
- JSON: https://secwatch.observer/filing/0001104659-25-120015.json
- Plain text: https://secwatch.observer/filing/0001104659-25-120015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.